Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
6
|
Resverlogix Corp.
|
Mar 18, 2022 01:34PM
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
6
|
Resverlogix Corp.
|
Mar 26, 2020 02:53PM
|
Re: Saudi
|
6
|
Resverlogix Corp.
|
Jan 15, 2021 11:54AM
|
Re: Covid 19 trial
|
6
|
Resverlogix Corp.
|
Jun 04, 2021 11:32AM
|
Re: Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
|
6
|
Resverlogix Corp.
|
Oct 26, 2023 12:50PM
|
GV on stock house
|
6
|
Resverlogix Corp.
|
Apr 08, 2021 11:18AM
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
6
|
Resverlogix Corp.
|
Apr 14, 2021 10:45PM
|
Re: Heart failure study
|
6
|
Resverlogix Corp.
|
Feb 07, 2021 11:54AM
|
Re: Drop in price
|
6
|
Resverlogix Corp.
|
Jul 08, 2021 04:43PM
|
on the bright side our biggest partner Hepalink
|
6
|
Resverlogix Corp.
|
Sep 24, 2019 05:49PM
|
Re: Drop in price
|
6
|
Resverlogix Corp.
|
Jul 08, 2021 05:22PM
|
Expectations for the AGM?
|
6
|
Resverlogix Corp.
|
Dec 06, 2020 12:43PM
|
jonzobot,Tada,10 baggar Plad etc etc
|
6
|
Resverlogix Corp.
|
Mar 25, 2021 11:05AM
|
Re: Another crazy week....
|
6
|
Resverlogix Corp.
|
Mar 20, 2020 05:46PM
|
Re: This Covid 19 possibility has
|
6
|
Resverlogix Corp.
|
Mar 24, 2020 10:44PM
|
Re: Potential funding for BETONMACE2 and Covid trial
|
6
|
Resverlogix Corp.
|
Oct 26, 2021 10:59AM
|
Re: COVID 19 / varients
|
6
|
Resverlogix Corp.
|
Apr 11, 2022 02:19PM
|
Re: Patience
|
6
|
Resverlogix Corp.
|
Jun 19, 2021 10:32AM
|
Re: Give us just one or two NR’s - money, partners & timeframe
|
6
|
Resverlogix Corp.
|
Apr 13, 2021 03:12PM
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
6
|
Resverlogix Corp.
|
Dec 13, 2021 02:46PM
|